Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus

Author:

De Vries Maaike C.1ORCID,Brown David A.2,Allen Mitchell E.2,Bindoff Laurence34,Gorman Gráinne S.56,Karaa Amel7,Keshavan Nandaki89,Lamperti Costanza10,McFarland Robert56,Ng Yi Shiau56,O'Callaghan Mar1112,Pitceathly Robert D. S.13,Rahman Shamima89,Russel Frans G. M.14,Varhaug Kristin N.34,Schirris Tom J. J.14,Mancuso Michelangelo15

Affiliation:

1. Radboudumc Amalia Children's Hospital Radboud Center for Mitochondrial Medicine Nijmegen The Netherlands

2. Department of Human Nutrition, Foods, and Exercise and the Virginia Tech Center for Drug Discovery Virginia Tech Blacksburg Virginia

3. Department of Clinical Medicine University of Bergen Bergen Norway

4. Department of Neurology Haukeland University Hospital Bergen Norway

5. Wellcome Centre for Mitochondrial Research, Institute of Neuroscience Newcastle University Newcastle upon Tyne UK

6. The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne UK

7. Genetics Unit, Massachusetts General Hospital Harvard Medical School Boston Massachusetts

8. Mitochondrial Research Group UCL Great Ormond Street Institute of Child Health London UK

9. Metabolic Unit Great Ormond Street Hospital NHS Foundation Trust London UK

10. Unit of Medical Genetics and Neurogenetics Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy

11. Department of Neurology, Metabolic Unit Hospital Sant Joan de Déu Barcelona Spain

12. CIBERER Instituto de Salud Carlos III Barcelona Spain

13. Department of Neuromuscular Diseases UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery London UK

14. Department of Pharmacology and Toxicology Radboud Institute for Molecular Life Sciences, Radboud Center for Mitochondrial Medicine, Radboudumc Nijmegen The Netherlands

15. Department of Clinical and Experimental Medicine, Neurological Institute University of Pisa Pisa Italy

Funder

European Molecular Biology Organization

Fondazione Telethon

Instituto de Salud Carlos III

Medical Research Council

Wellcome Trust

Prinses Beatrix Spierfonds

National Institute for Health Research

Newcastle upon Tyne Hospitals NHS Foundation Trust

Biotechnology and Biological Sciences Research Council

Newcastle University

European Commission

Virginia Polytechnic Institute and State University

National Institute of Food and Agriculture

National Institutes of Health

Medical Research Council Canada

Action Medical Research

NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research

Muscular Dystrophy UK

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3